These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26406953)

  • 41. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer.
    Zhang J; Yu XL; Zheng GF; Zhao F
    Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Raf1 is a prognostic factor for progression in patients with non‑small cell lung cancer after radiotherapy.
    Tian H; Yin L; Ding K; Xia YY; Wang XH; Wu JZ; He X
    Oncol Rep; 2018 Apr; 39(4):1966-1974. PubMed ID: 29484414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
    Lin Q; Chen T; Lin Q; Lin G; Lin J; Chen G; Guo L
    J Surg Oncol; 2013 Jun; 107(7):767-71. PubMed ID: 23609137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic values of ERK1/2 and p-ERK1/2 expressions for poor survival in non-small cell lung cancer.
    Zhao S; Qiu ZX; Zhang L; Li WM
    Tumour Biol; 2015 Jun; 36(6):4143-50. PubMed ID: 25596700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
    Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
    Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
    Li L; Mei TH; Zhou XD; Zhang XG
    Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
    Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
    Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer.
    Chen P; Li WM; Lu Q; Wang J; Yan XL; Zhang ZP; Li XF
    BMC Cancer; 2014 Jun; 14():402. PubMed ID: 24894011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inversin correlates with the malignant phenotype of non-small cell lung cancer and promotes the invasiveness of lung cancer cells.
    Jiang GY; Zhang Y; Zhang XP; Lin XY; Yu JH; Wang EH
    Tumour Biol; 2017 Jun; 39(6):1010428317691177. PubMed ID: 28618971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PinX1 Is a Potential Prognostic Factor for Non-Small-Cell Lung Cancer and Inhibits Cell Proliferation and Migration.
    Wang S; Zhang H; Zhu J; Li C; Zhu J; Shi B; Zhang B; Wang C
    Biomed Res Int; 2017; 2017():7956437. PubMed ID: 28815183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.
    Gueugnon F; Barascu A; Mavridis K; Petit-Courty A; Marchand-Adam S; Gissot V; Scorilas A; Guyetant S; Courty Y
    Tumour Biol; 2015 Jul; 36(7):4979-86. PubMed ID: 25677900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
    Zhang Z; Wang Q; Chen F; Liu J
    Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis.
    Duan L; Hu X; Jin Y; Liu R; You Q
    BMC Cancer; 2016 Apr; 16():276. PubMed ID: 27090386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notch-regulated ankyrin-repeat protein is a novel tissue biomarker that predicts poor prognosis in non-small cell lung cancer.
    Liao Y; Chen J; Ma J; Mao Q; Wei R; Zheng J
    Oncol Lett; 2018 Aug; 16(2):1885-1891. PubMed ID: 30008880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer.
    Luo X; Hou N; Chen X; Xu Z; Xu J; Wang L; Yang S; Liu S; Xu L; Chen Y; Xiong L; Wang J; Fan W; Xu J
    Cancer Biomark; 2018 Feb; 21(2):461-469. PubMed ID: 29171988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coexpression of c-Met and Notch-1 correlates with poor prognosis in resected non-small-cell lung cancer.
    Wang X; Song N; Zhang Y; Cai Y; Liu Y; Qu X; Li Z; Li D; Hou K; Kang J; Hu X
    Tumour Biol; 2015 Sep; 36(9):7053-9. PubMed ID: 25869878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis.
    Wang XW; Cai CL; Xu JM; Jin H; Xu ZY
    Tumour Biol; 2015 Feb; 36(2):901-7. PubMed ID: 25304157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer.
    Gu X; Tian T; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
    Tumour Biol; 2015 Apr; 36(4):2651-6. PubMed ID: 25480413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of KIAA1199: An independent prognostic marker in nonsmall cell lung cancer.
    Deng F; Lei J; Zhang X; Huang W; Li Y; Wu D
    J Cancer Res Ther; 2017; 13(4):664-668. PubMed ID: 28901311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PPM1H is an independent prognostic biomarker of non-small cell lung cancer.
    Zhang WQ; Gao JN; Chen XL; Yang XF
    Neoplasma; 2021 Sep; 68(5):917-923. PubMed ID: 33847131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.